{"url_path":"/sec/mdt/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 Exhibits and Financial Statement Schedules","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/1613103/0001628280-26-044354-index.html","accession_number":"0001628280-26-044354","cik":"0001613103","ticker":"MDT","issuer_name":"Medtronic plc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1613103/0001628280-26-044354-index.html","primary_entity_key":"0001613103","primary_entity_name":"Medtronic plc"},"word_count":3606,"has_tables":true,"body_markdown":"Item 15. Exhibits and Financial Statement Schedules\n\n(a)1. Financial Statement Schedule\n\n \nSchedule II. Valuation and Qualifying Accounts — fiscal years 2026, 2025, and 2024.\n\nMEDTRONIC PLC AND SUBSIDIARIES\n\nSCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS\n\n(in millions)\n\nAdditionsDeductions\n\nBalance at\nBeginning of\nFiscal YearCharges to IncomeCharges to Other AccountsOther Changes (Debit) CreditBalance\nat End of\nFiscal Year\n\nAllowance for credit losses:     \n\nFiscal year 2026\n$199 $136 $— $(145)(a)$190 \n\nFiscal year 2025\n173 123 — (97)(a)199 \n\nFiscal year 2024\n176 90 — (93)(a)173 \n\nDeferred tax valuation allowance:\n\nFiscal year 2026\n$12,668 $177 $4 (d)$(511)(c)$12,338 \n\nFiscal year 2025\n13,271 151 9 (d)(195)(c)12,668 \n\n (567)(e)\n\nFiscal year 2024\n11,311 1,522 3 (b)(108)(c)13,271 \n\n545 (e)(2)(d)\n\n(a) Primarily consists of uncollectible accounts written off, less recoveries.\n\n(b) Reflects the impact from acquisitions.\n\n(c) Primarily reflects carryover attribute utilization and expiration.\n\n(d) Primarily reflects the effects of currency fluctuations.\n\n(e) Primarily reflects the impacts from tax rate changes.\n\nAll other schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.\n\n2. Exhibits\n\nExhibit No.Description\n\n3.1\n[Certificate of Incorporation of Medtronic plc (incorporated by reference to Exhibit 3.1 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515020681/d859999dex31.htm)\n\n3.2\n[Amended and Restated Memorandum and Articles of Association of Medtronic plc (incorporated by reference to Exhibit 3.1 to Medtronic plc’s Current Report on Form 8-K, filed on October 21, 2025, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000162828025045695/amendedandrestatedmemorand.htm)\n\n4.1\n[Form of Indenture between Medtronic, Inc. and Wells Fargo Bank, National Association regarding 2009 offering (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Registration Statement on Form S-3, filed on March 9, 2009, File No. 333-157777).](https://www.sec.gov/Archives/edgar/data/64670/000095013709001623/c49806exv4w1.htm)\n\n4.2\n[First Supplemental Indenture, dated March 12, 2009, between Medtronic, Inc. and Wells Fargo Bank, National Association (including the Forms of Notes thereof) (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Current Report on Form 8-K, filed on March 12, 2009, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000095013709001761/c50013exv4w1.htm)\n\n4.3\n[Second Supplemental Indenture, dated March 16, 2010, between Medtronic, Inc. and Wells Fargo Bank, National Association (including the Forms of Notes thereof) (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Current Report on Form 8-K, filed on March 16, 2010, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000095012310025103/c56981exv4w1.htm)\n\n119\n\n[Table of Contents](#i8ac9545bba26417b86662fb12ca4cf78_7)\n\n4.4\n[Fourth Supplemental Indenture, dated March 19, 2012, between Medtronic, Inc. and Wells Fargo Bank, National Association (including the Forms of Notes thereof) (incorporated by reference to Exhibit 4.2 to Medtronic, Inc.’s Current Report on Form 8-K, filed on March 20, 2012, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000119312512123407/d318842dex42.htm)\n\n4.5\n[Fifth Supplemental Indenture, dated March 26, 2013, between Medtronic, Inc. and Wells Fargo Bank, National Association (including the Forms of Notes thereof) (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Current Report on Form 8-K, filed on March 26, 2013, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000119312513126071/d508677dex41.htm)\n\n4.6\n[Sixth Supplemental Indenture, dated February 27, 2014, between Medtronic, Inc. and Wells Fargo Bank, National Association (including the Form of Global Note thereof) (incorporated by reference to Exhibit 4.2 to Medtronic, Inc.’s Current Report on Form 8-K, filed on February 27, 2014, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000119312514072613/d684319dex42.htm)\n\n4.7\n[Seventh Supplemental Indenture, dated as of January 26, 2015, by and among Medtronic plc, Medtronic, Inc., Medtronic Global Holdings S.C.A. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 4.2 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021837/d859367dex42.htm)\n\n4.8\n[Indenture, dated December 10, 2014, between Medtronic, Inc. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Current Report on Form 8-K filed with the Commission on December 10, 2014, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000119312514439048/d835649dex41.htm)\n\n4.9\n[First Supplemental Indenture, dated December 10, 2014, between Medtronic, Inc. and Wells Fargo Bank, National Association (including Form of Floating Rate Senior Notes due 2020, Form of 1.500% Senior Notes due 2018, Form of 2.500% Senior Notes due 2020, Form of 3.150% Senior Notes due 2022, Form of 3.500% Senior Notes due 2025, Form of 4.375% Senior Notes due 2035 and Form of 4.625% Senior Notes due 2045) (incorporated by reference to Exhibit 4.2 of Medtronic, Inc.’s Current Report on Form 8-K filed with the Commission on December 10, 2014, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000119312514439048/d835649dex42.htm)\n\n4.10\n[Second Supplemental Indenture, dated as of January 26, 2015, by and among Medtronic plc and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 4.3 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021837/d859367dex43.htm)\n\n4.11\n[Third Supplemental Indenture, dated as of January 26, 2015, by and among Medtronic Global Holdings S.C.A. and Wells Fargo Bank, National Association (incorporated by reference to Exhibit 4.4 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021837/d859367dex44.htm)\n\n4.12\n[Fourth Supplemental Indenture to Medtronic, Inc. Senior Indenture, dated as of February 22, 2023, among Medtronic Global Holdings, S.C.A., Medtronic, Inc. and Medtronic plc and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, N.A.), as trustee (incorporated by reference to Exhibit 4.9 to Medtronic plc’s Registration Statement on Form S-3, filed on March 3, 2023)](https://www.sec.gov/Archives/edgar/data/64670/000119312523060059/d449390dex49.htm)\n\n4.13\n[Fifth Supplemental Indenture to Medtronic, Inc. Senior Indenture, dated as of June 3, 2024, among Medtronic, Inc., Medtronic plc, Medtronic Global Holdings S.C.A., Computershare Trust Company, N.A., as trustee, and Elavon Financial Services DAC, UK Branch (incorporated by reference to Exhibit 4.1 to Medtronic plc’s Form 8-K, filed on June 3, 2024)](https://www.sec.gov/Archives/edgar/data/1613103/000119312524152334/d811133dex41.htm)\n\n4.14\n[Sixth Supplemental Indenture](https://www.sec.gov/Archives/edgar/data/1613103/000119312525221819/d73148dex41.htm)[, dated as of September 29, 2025, among Medtronic, Inc., Medtronic plc,](https://www.sec.gov/Archives/edgar/data/1613103/000119312525221819/d73148dex41.htm)[and](https://www.sec.gov/Archives/edgar/data/1613103/000119312525221819/d73148dex41.htm)[Medtronic Global Holdings S.C.A., Computershare Trust Company, N.A.,](https://www.sec.gov/Archives/edgar/data/1613103/000119312525221819/d73148dex41.htm)[as successor to Wells Fargo Bank, N.A.,](https://www.sec.gov/Archives/edgar/data/1613103/000119312525221819/d73148dex41.htm)[as trustee, and U.S. Bank Europe DAC, UK Branch (incorporated by reference to Exhibit 4.1 to Medtronic plc’s Form 8-K, filed on September 29, 2025)](https://www.sec.gov/Archives/edgar/data/1613103/000119312525221819/d73148dex41.htm)\n\n4.15\n[Indenture, dated as of October 22, 2007, by and among Covidien International Finance S.A., Covidien Ltd. and Deutsche Bank Trust Company Americas (incorporated by reference to Exhibit 4.1(a) to Covidien plc’s Current Report on Form 8-K filed on October 22, 2007, File No. 001-33259).](https://www.sec.gov/Archives/edgar/data/1385187/000119312507222875/dex41a.htm)\n\n4.16\n[Fourth Supplemental Indenture, dated as of October 22, 2007, by and among Covidien International Finance S.A., Covidien Ltd. and Deutsche Bank Trust Company Americas (incorporated by reference to Exhibit 4.1(e) to Covidien plc’s Current Report on Form 8-K filed on October 22, 2007, File No. 001-33259).](https://www.sec.gov/Archives/edgar/data/1385187/000119312507222875/dex41e.htm)\n\n4.17\n[Ninth Supplemental Indenture, dated as of January 26, 2015, by and among Medtronic plc, Medtronic Global Holdings S.C.A., Covidien public limited company, Covidien International Finance S.A., Covidien Ltd. and Deutsche Bank Trust Company Americas (incorporated by reference to Exhibit 4.5 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021837/d859367dex45.htm)\n\n4.18\n[Senior Indenture, dated as of March 28, 2017, by and among Medtronic plc, Medtronic Global Holdings S.C.A., Medtronic, Inc., and Wells Fargo Bank, N.A. (incorporated by reference to Exhibit 4.1 to Medtronic plc’s Current Report on Form 8-K, filed on March 28, 2017, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312517099886/d290589dex41.htm)\n\n4.19\n[Second Supplemental Indenture, dated as of March 7, 2019, by and among Medtronic plc, Medtronic Global Holdings S.C.A., Medtronic, Inc., Wells Fargo Bank, N.A., and Elavon Financial Services DAC, UK Branch (incorporated by reference to Exhibit 4.1 to Medtronic plc’s Current Report on Form 8-K, filed on March 7, 2019, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312519066295/d710754dex41.htm)\n\n120\n\n[Table of Contents](#i8ac9545bba26417b86662fb12ca4cf78_7)\n\n4.20\n[Third Supplemental Indenture, dated as of July 2, 2019, among Medtronic Global Holdings S.C.A., Medtronic, Inc. and Medtronic plc, Wells Fargo Bank, N.A., as trustee, and Elavon Financial Services DAC (incorporated by reference to Exhibit 4.1 to Medtronic plc' Current Report on Form 8-K, filed July 2, 2019, File No. 001-36820)](https://www.sec.gov/Archives/edgar/data/1613103/000119312519187797/d762838dex41.htm).\n\n4.21\n[Fourth Supplemental Indenture, dated as of September 29, 2020, among Medtronic Global Holdings S.C.A., Medtronic, Inc. and Medtronic plc, Wells Fargo Bank, N.A., as trustee, and Elavon Financial Services DAC, as paying agent (including the forms of the 2023 Notes, the 2025 Notes, the 2028 Notes, the 2032 Notes, the 2040 Notes and the 2050 Notes) (incorporated by reference to Exhibit 4.1 to Medtronic plc' Current Report on Form 8-K, filed September 29, 2020, File No. 001-36820)](https://www.sec.gov/Archives/edgar/data/0001613103/000119312520257811/d19681dex41.htm).\n\n4.22\n[Fifth Supplemental Indenture, dated as of September 21, 2022, among Medtronic Global Holdings S.C.A., Medtronic, Inc. and Medtronic plc, Computershare Trust Company, N.A., as successor to Wells Fargo Bank, N.A., as trustee, and Elavon Financial Services DAC, as paying agent (including the forms of the 2025 Notes, the 2028 Notes, the 2031 Notes and the 2034 Notes) (incorporated by reference to Exhibit 4.1 to Medtronic plc’s Current Report on Form 8-K filed on September 21, 2022, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312522248112/d406839dex41.htm)\n\n4.23\n[Sixth Supplemental Indenture, dated as of February 22, 2023, among Medtronic Global Holdings S.C.A., Medtronic, Inc. and Medtronic plc, and Computershare Trust Company, N.A., as successor to Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 4.2 to Medtronic plc’s Registration Statement on Form S-3, filed on March 3, 2023, File No. 333-270272).](https://www.sec.gov/Archives/edgar/data/1613103/000119312523060059/d449390dex42.htm)\n\n4.24\n[Seventh Supplemental Indenture, dated as of March 30, 2023, among Medtronic Global Holdings S.C.A., Medtronic, Inc. and Medtronic plc, and Computershare Trust Company, N.A., as successor to Wells Fargo Bank, N.A., as trustee (including the forms of the 2028 Notes and the 2033 Notes) (incorporated by reference to Exhibit 4.2 to Medtronic plc’s Current Report on Form 8-K filed on March 30, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312523085642/d490503dex42.htm)\n\n#4.25\n[Description of Registrant's Securities](mdt-202610kxex425.htm).\n\n10.1\n[Amended and Restated Credit Agreement, dated as of December 12, 2018, by and among Medtronic Global Holdings, SCA, certain subsidiaries named therein, Medtronic, Inc., Medtronic PLC, the lenders from time to time party thereto, and Bank of America, N.A. as Administration Agent (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Current Report on Form 8-K, filed on December 13, 2018, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312518348880/d672316dex101.htm)\n\n10.2\n[Amendment No. 1 and Extension Agreement to the Amended and Restated Credit Agreement, dated as of December 12, 2019, among Medtronic Global Holdings S.C.A., Medtronic, Inc., Medtronic PLC, the Lenders party thereto and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Current Report on Form 10-Q, filed on February 28, 2020, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/exhibit101amendedandre.htm)\n\n10.3\n[Amendment No. 2 and Extension Agreement to the Amended and Restated Credit Agreement dated as of December 12, 2020 (incorporated by reference to Exhibit 10.85 to Medtronic plc’s Annual Report on Form 10-K for the year ended April 28, 2023, filed on June 22, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-202310kxex1085.htm)\n\n10.4\n[Amendment No. 3 and Extension Agreement to the Amended and Restated Credit Agreement, dated as of December 13, 2021, by and among Medtronic Global Holdings S.C.A., certain subsidiaries of Medtronic plc from time to time party thereto, Medtronic, Inc., Medtronic plc, the lenders from time to time party thereto and Bank of America N.A., as administrative agent. (incorporated by reference to Exhibit 10.01 to Medtronic plc’s Current Report on Form 8-K, filed on December 14, 2021, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310321000065/exhibit1001-amendmentno3an.htm)\n\n10.5\n[Amendment No. 4 and Extension Agreement to the Amended and Restated Credit Agreement dated as of December 12, 2022 (incorporated by reference to Exhibit 10.1 to Medtronic plc's Quarterly Report on Form 10-Q for the quarter ended January 27, 2023, filed on March 1, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/mdt-2023q310xqxex101.htm)\n\n10.6\n[Annex I to Amendment No. 4 and Extension Agreement to the Amended and Restated Credit Agreement dated as of December 12, 2022 (incorporated by reference to Exhibit 10.2 to Medtronic plc's Quarterly Report on Form 10-Q for the quarter ended January 27, 2023, filed on March 1, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/mdt-2023q310xqxex102.htm)\n\n#10.7\n[Amendment No. 5 and Extension Agreement to the Amended and Restated Credit Agreement dated as of December 12, 2022.](mdt-2026xex107xamendmentno.htm)\n\n10.8\n[Form of Deed of Indemnification (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021837/d859367dex101.htm)\n\n10.9\n[Form of Indemnification Agreement (incorporated by reference to Exhibit 10.2 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021837/d859367dex102.htm)\n\n*10.10\n[Change of Control Severance Plan - Section 16B Officers (as amended and restated as of January 26, 2015) (incorporated by reference to Exhibit 10.14 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515020690/d858587dex1014.htm)\n\n121\n\n[Table of Contents](#i8ac9545bba26417b86662fb12ca4cf78_7)\n\n*10.11\n[Office of Chairman and Chief Executive Officer Letter Agreement (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Quarterly Report on Form 10-Q, filed on December 3, 2019, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/officeofchairmanandchi.htm)\n\n*10.12\n[Letter Agreement by and between Medtronic, Inc. and Thierry Piéton dated December 24, 2024 (incorporate](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/ex101-letteragreementbyand.htm)[d](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/ex101-letteragreementbyand.htm)[by reference to Exhibit 10.1 to Medtronic, plc's Quarterly Report on Form 10-Q, filed on February 25, 2025).](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/ex101-letteragreementbyand.htm)\n\n#*10.13\n[Letter Agreement by and between Medtronic, Inc. and Michelle Quinn, dated June 18, 2025.](mdt-2026xex1013letteragree.htm)\n\n#*10.14\n[Terms of Non-Employee Director Compensation.](mdt-2026xex1014termsofnonx.htm)\n\n*10.15\n[1998 Outside Director Stock Compensation Plan (as amended and restated effective as of January 1, 2008) (incorporated by reference to Exhibit 10.3 to Medtronic, Inc.’s Quarterly Report on Form 10-Q for the quarter ended January 25, 2008, filed on, filed on March 4, 2008, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000089710108000478/medtronic080932_ex10-3.htm)\n\n*10.16\n[Amendment to the 1998 Outside Director Stock Compensation Plan (incorporated by reference to Exhibit 10.2 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021907/d858587dex102.htm)\n\n*10.17\n[2003 Long-Term Incentive Plan (as amended and restated effective January 1, 2008) (incorporated by reference to Exhibit 10.4 to Medtronic, Inc.’s Quarterly Report on Form 10-Q for the quarter ended January 28, 2008, filed on March 4, 2008, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000089710108000478/medtronic080932_ex10-4.htm)\n\n*10.18\n[Amendment to the 2003 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515021907/d858587dex103.htm)\n\n*10.19\n[2008 Stock Award and Incentive Plan (as amended and restated effective August 27, 2009) (incorporated by reference to Exhibit 10.2 to Medtronic, Inc.’s Quarterly Report on Form 10-Q for the quarter ended October 30, 2009, filed on December 9, 2009, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000089710109002528/medtronic095603_ex10-2.htm)\n\n*10.20\n[Amendment to the 2008 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.4 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515020690/d858587dex104.htm)\n\n*10.21\n[Form of Non-Employee Director Deferred Unit Award Agreement under 2008 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.3 to Medtronic, Inc.’s Quarterly Report on Form 10-Q for the quarter ended October 24, 2008, filed on December 3, 2008, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000089710108002439/medtronic084960_ex10-3.htm)\n\n*10.22\n[Medtronic plc Amended and Restated 2013 Stock Award and Incentive Plan (as amended and restated generally effective December 8, 2017) (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Current Report on Form 8-K, filed on December 12, 2017, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310317000055/exhibit101medtronicplcamen.htm)\n\n*10.23\n[Form of Non-qualified Stock Option Agreement Amended and Restated 2013 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.50 to Medtronic plc’s Annual Report on Form 10-K, filed June 22, 2018, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/exhibit1050.htm)\n\n*10.24\n[Form of Long Term Performance Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.53 to Medtronic plc’s Annual Report on Form 10-K, filed June 22, 2018, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/exhibit1053.htm)\n\n*10.25\n[Form of Performance Share Unit Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended October 30, 2020, filed on December 3, 2020, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/ex101-formofperformanc.htm)\n\n*10.26\n[Form of Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.3 to Medtronic, Inc.’s Quarterly Report on Form 10-Q for the quarter ended October 24, 2008, filed on December 3, 2008, File No. 001-07707).](https://www.sec.gov/Archives/edgar/data/64670/000089710108002439/medtronic084960_ex10-3.htm)\n\n*10.27\n[Form of Non-Qualified Stock Option Agreement under Amended and Restated 2013 Stock Award and Incentive Plan (incorporated by reference to Exhibit 10.70 to Medtronic plc’s Annual Report on Form 10-K for the year ended April 24, 2020, filed on June 19, 2020, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/mdt202010k-ex1070.htm)\n\n*10.28\n[Medtronic plc Incentive Plan (as amended and restated effective January 26, 2015) (incorporated by reference to Exhibit 10.11 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515020690/d858587dex1011.htm)\n\n*10.29\n[Medtronic plc Supplemental Executive Retirement Plan (as restated generally effective January 26, 2015) (incorporated by reference to Exhibit 10.15 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515020690/d858587dex1015.htm)\n\n*10.30\n[Medtronic Non-Qualified Retirement Plan Supplemental (restated November 6, 2020, and formerly known as the Supplemental Executive Retirement Plan) (incorporated by reference to Exhibit 10.3 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended October 30, 2020, filed on December 3, 2020, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/ex103-medtronicnonxqua.htm)\n\n122\n\n[Table of Contents](#i8ac9545bba26417b86662fb12ca4cf78_7)\n\n*10.31\n[Medtronic plc Savings and Investment Plan (as amended and restated generally effective January 26, 2015) (incorporated by reference to Exhibit 4.22 to Medtronic plc’s Registration Statement on Form S-8 filed on January 28, 2015, File No. 333-201737).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515023510/d859659dex422.htm)\n\n*10.32\n[Medtronic plc Capital Accumulation Plan Deferral Program (as amended and restated generally effective January 26, 2015) (incorporated by reference to Exhibit 10.13 to Medtronic plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000119312515020690/d858587dex1013.htm)\n\n*10.33\n[Capital Accumulation Plan Deferral Program (as amended and restated generally effective January 1, 2017) (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended October 28, 2016, filed on December 5, 2016, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/exhibit101-medtronicplccap.htm)\n\n*10.34\n[Amended and Restated Covidien Supplemental Savings and Retirement Plan (restated November 6, 2020) (incorporated by reference to Exhibit 10.2 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended October 30, 2020, filed on December 3, 2020, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/ex102-amendedandrestat.htm)\n\n*10.35\n[Medtronic Capital Accumulation Plan Deferral Program (restated November 6, 2020) (incorporated by reference to Exhibit 10.4 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended October 30, 2020, filed on December 3, 2020, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/ex104-medtroniccapital.htm)\n\n*10.36\n[Medtronic Capital Accumulation Plan Deferral Program (as restated generally effective January 1, 2017) (Conformed through the Amendment generally effective as of January 1, 2022) (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended January 28, 2022, filed on March 3, 2022, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/mdt-2022q310qxex101.htm)\n\n*10.37\n[2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended January 28, 2022, filed on March 3, 2022, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/mdt-2022q310qxex102.htm)\n\n*10.38\n[Performance Share Unit Agreement 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.3 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended January 28, 2022, filed on March 3, 2022, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/mdt-2022q310qxex103.htm)\n\n*10.39\n[Non-Qualified Stock Option Agreement 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended January 28, 2022, filed on March 3, 2022, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/mdt-2022q310qxex104.htm)\n\n*10.40\n[Restricted Stock Unit Award Agreement for awards vesting ratably on the first, second, third, and fourth anniversary of the grant date - 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.6 to Medtronic plc’s Quarterly Report on Form 10-Q for the quarter ended January 28, 2022, filed on March 3, 2022, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/mdt-2022q310qxex106.htm)\n\n10.41\n[Medtronic Nonqualified Retirement Plan Supplement dated as of April 28, 2023 (incorporated by reference to Exhibit 10.86 to Medtronic plc’s Annual Report on Form 10-K for the year ended April 28, 2023, filed on June 22, 2023, File No. 001-36820)](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-202310kxex1086.htm)\n\n*10.42\n[Performance Share Unit Award Agreement 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Quarterly Report on Form 10-Q filed on August 31, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/mdt-2024q110qxex101.htm)\n\n*10.43\n[Restricted Stock Unit Award Agreement 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.2 to Medtronic plc’s Quarterly Report on Form 10-Q filed on August 31, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/mdt-2024q110qxex102.htm)\n\n*10.44\n[Restricted Stock Unit Award Agreement 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.3 to Medtronic plc’s Quarterly Report on Form 10-Q filed on August 31, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/mdt-2024q110qxex103.htm)\n\n*10.45\n[Non-Qualified Stock Option Agreement 2021 Medtronic plc Long Term Incentive Plan (incorporated by reference to Exhibit 10.4 to Medtronic plc’s Quarterly Report on Form 10-Q filed on August 31, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/mdt-2024q110qxex104.htm)\n\n*10.46\n[Medtronic plc 2024 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 to Medtronic plc’s Current Report on Form 8-K filed on October 23, 2023, File No. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/exhibit101-medtronicplc202.htm)\n\n10.47\n[Medtronic Nonqualified Retirement Plan Supplement (as amended and restated effective March 3, 2025) (incorporate](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/mdt-202510xkxex1081.htm)[d](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/mdt-202510xkxex1081.htm)[by reference to Exhibit 10.81 to Medtronic plc’s Annual Report on Form 10-K for the year ended April 25, 2025, File No](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/mdt-202510xkxex1081.htm)[. 001-36820).](https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/mdt-202510xkxex1081.htm)\n\n#19\n[Medtronic plc Global Insider Trading Policy](mdt-202610kxex19.htm)\n\n#21\n[List of Subsidiaries of Medtronic plc.](mdt-202610kxex21.htm)\n\n#22\n[List of Senior Notes, Issuers and Guarantors.](mdt-202610kxex22.htm)\n\n#23\n[Consent of Independent Registered Public Accounting Firm.](mdt-202610kxex23.htm)\n\n#24\n[Power of Attorney.](mdt-202610kxex24.htm)\n\n123\n\n[Table of Contents](#i8ac9545bba26417b86662fb12ca4cf78_7)\n\n#31.1\n[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mdt-202610kxex311.htm)\n\n#31.2\n[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](mdt-202610kxex312.htm)\n\n#32.1\n[Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](mdt-202610kxex321.htm)\n\n#32.2\n[Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](mdt-202610kxex322.htm)\n\n#97\n[Medtronic plc Policy For The Recovery of Erroneously Awarded Compensation](mdt-202610kxex97.htm)\n\n#101.SCHXBRL Taxonomy Extension Schema Document\n\n#101.CALXBRL Taxonomy Extension Calculation Linkbase Document\n\n#101.DEFXBRL Taxonomy Extension Definition Linkbase Document\n\n#101.LAB XBRL Taxonomy Extension Label Linkbase Document\n\n#101.PRE XBRL Taxonomy Extension Presentation Linkbase Document\n\n#104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n*Exhibits that are management contracts or compensatory plans or arrangements.\n\n#Filed herewith"}